Drug interactions
Empagliflozin-metformin + Lanreotide
Severity: Moderate
Empagliflozin-metformin and Lanreotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Lanreotide suppresses insulin, glucagon and incretin secretion, which can cause either hyperglycemia or hypoglycemia. Glycemic control may change in patients on antidiabetic drugs.
What this interaction means in plain words
Empagliflozin-metformin and Lanreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Empagliflozin-metformin belongs to Endocrine; Lanreotide belongs to Endocrine.
Why it happens
Somatostatin analogue activity inhibits pancreatic insulin and glucagon secretion, producing unpredictable glycemic effects.
What to do
Monitor blood glucose when starting or changing the lanreotide dose. Adjust the antidiabetic regimen as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-metformin and Lanreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Empagliflozin-metformin
Other interactions of Lanreotide
- Lanreotide + Quinidine Major
- Alogliptin-metformin + Lanreotide Moderate
- Canagliflozin-metformin + Lanreotide Moderate
- Cyclosporin + Lanreotide Moderate
- Dapagliflozin-metformin + Lanreotide Moderate
- Glipizide-metformin + Lanreotide Moderate
Frequently asked questions
Can I take Empagliflozin-metformin with Lanreotide?
MediHelp rates the interaction as moderate. Empagliflozin-metformin and Lanreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lanreotide suppresses insulin, glucagon and incretin secretion, which can cause either hyperglycemia or hypoglycemia. Glycemic control may change in patients on antidiabetic drugs.
How serious is the interaction between Empagliflozin-metformin and Lanreotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or changing the lanreotide dose. Adjust the antidiabetic regimen as needed.
What other medicines interact with Empagliflozin-metformin?
MediHelp also lists interactions of Empagliflozin-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Empagliflozin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
